Intelligence / Healthtech / FDA 510(k) Clearances / Diagnostica Stago, Inc.
Approvalsdevice cleared24 Sept 2026
Diagnostica Stago, Inc.
24 Sept 2026: Device cleared · STA® - Liquid Anti-Xa. Recorded in the openFDA device 510(k) data.
- Decided
- 24 Sept 2026
- Device
- STA® - Liquid Anti-Xa
- Specialty
- Hematology
- Country
- United States
- Location
- Parsippany, NJ
- Clearance type
- Special
- 510(k) number
- K260214
- Submitted
- 2026-01-23
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at Diagnostica Stago, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Diagnostica Stago, Inc. in our registers.
More in Hematology
FDA 510(k) Clearances
27 OctSienco, Inc.device cleared · Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot Viewer (SCP1); Sonoclot Coagulation & Platelet Function Analzyer System with Sonoclot Viewer (SCP2); Sonoclot Coagulation Analyzer System with Sonoclot Viewer (SC1)Approvals20 OctBd Biosciencesdevice cleared · BD OneFlow LST; BD OneFlow B-CLPD T1; BD FACSLyric Flow Cytometer, 8-color [4-2-2], 10-color [4-3-3], 12-color (4-3-5)Approvals14 SeptHORIBA ABX SASdevice cleared · Yumizen H550Approvals11 AugSiemens Healthcare Diagnostic Products GmbHdevice cleared · INNOVANCE® D-Dimer 2.0 (SMN 10873803)Approvals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.